Accreditation in the Medical Physics and Clinical Engineering Area - UKAS has undertaken pilot assessments under its Medical Physics and Clinical Engineering (MPACE) scheme in the areas of Radiotherapy Physics and Clinical Engineering against the requirements of BS 70000.  In discussion with the MPACE Technical Advisory Committee, British Nuclear Medicine Society (BNMS) and IPEM, UKAS is now looking to extend the scheme into the area of Nuclear Medicine.  A call for expression of interests can be found on the following UKAS website

https://www.ukas.com/services/technical-services/development-of-new-areas-of-accreditation/current-pilot-projects/medical-physics-and-clinical-engineering-mpace/

To all BNMS Members,

We want to thank you for your continued support.

Your membership has allowed us to achieve so much this year

A letter from BNMS President, John Buscombe on Brexit and disruption to the supply of radiopharmaceuticals.

red_risk.pdf

Dr Buscombe, the BNMS President Elect was one of the witnesses at a recent House of Lords Commitee looking at the consequences of leaving Euratom

Below is the link to the debate. 

View the programme here

Dr John Buscombe is also quoted in an article in the Independent, view the link here

Press Statement on Euratom and supply of medical isotopes following Brexit from the British Nuclear Medicine Society, supported by the Royal College of Radiologists and Royal College of Physicians

On Wednesday 12 July there was a parliamentary debate on the implications for the UK on withdrawing from the Euratom Treaty. Since 1957 the Euratom framework has enshrined the regulation and safeguards for the transportation and use of radioactive materials and governs UK international nuclear cooperation agreements with European and third party countries, including Canada, Japan and the USA. Withdrawing from Euratom will affect the arrangements for the supply and use of radioactive isotopes to industry, power generation, academia and medicine.